COVID-19

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has received Conformité Européene (CE) mark approval across 28 countries in the EU. With CE approval, our antibody test will be available in a variety of healthcare centers such as clinics and hospital emergency rooms.

ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval Read More »

NOWDiagnostics seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test

NOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test The ADEXUSDx® COVID-19 Test is a rapid serology test that detects total antibodies to SARS-CoV-2. It provides in-field, lab accurate results within 15 minutes, using as little as a drop of blood. The test does not require buffers or reagents, lab equipment, refrigeration, or in demand ancillary

NOWDiagnostics seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test Read More »